Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 709 (USA) (Dr. Novak)
· consented 2012-12-23
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate BLOOD ALKALINE PHOSPHATASE INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-12 (study day 141.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2011-11; relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.